2-Oxabicyclo[2.2.2]octan-6-ol, 1,3,3-trimethyl-, acetate
Common Name: |
2-Oxabicyclo[2.2.2]octan-6-ol, 1,3,3-trimethyl-, acetate |
IUPAC Name: |
(1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-yl) acetate |
Molecular Formula: |
C12H20O3 |
SMILES: |
CC(=O)OC1CC2CCC1(OC2(C)C)C |
Inchi: |
1S/C12H20O3/c1-8(13)14-10-7-9-5-6-12(10,4)15-11(9,2)3/h9-10H,5-7H2,1-4H3 |
Inchi Key: |
XRKZFZWIYZDOQO-UHFFFAOYSA-N |
Cas No: |
72257-53-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
212.29 |
Mass (g/mol) |
212.141 |
Molar Refractivity |
58.02 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
2 |
Rings |
3 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
253.00 to 254.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.018 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.92 |
LogP |
2.286 |
iLOGP |
2.82 |
XLOGP3 |
1.78 |
WLOGP |
2.29 |
MLOGP |
1.88 |
ESOL Log S |
-2.15 |
ESOL Solubility (mg/ml) |
1.52 |
ESOL Solubility (mol/l) |
0.007 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.14 |
Ali Solubility (mg/ml) |
1.52 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.32 |
Silicos-IT Solubility (mg/ml) |
1.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.33 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.732 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.59 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
1 |
OCT2 inhibitor |
0 |